Thall, Aron External Entity

Publications

Sort by

Selected publications

  • Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology2005 Academic Article GET IT

Other